Mutations in TAP1 result in immune-related diseases such as MHC class I deficiency (Hanalioglu et al., 2017) but are also associated with cardiometabolic diseases, such as type 2 diabetes (Li et al., 2014). This evidence concerns the gene TAP1 and Immunodeficiency by defective expression of HLA class 1.